Doctor profile · Federal record
Dr. Michelle Dallapiazza, MD
Infectious Disease Physician (CMS: Infectious Disease) · Infectious Disease Physician · Infectious Disease Physician · Chicago, IL
- NPI 1871656215
- Accepts Medicare
- MIPS 63.5 / 100 · 2023
- 20 yrs in practice
- Licensed in 3 states
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
4025 N Sheridan RD
Chicago, IL 606132010
(773) 388-1600 - Additional location
-
140 Bergen St, D Level
Newark, NJ 071032425
(973) 972-5111 - Mailing address
-
140 Bergen St, D Level
Newark, NJ 071032425
Credentials & registration
- NPI registered
- December 2006 — 20 yrs on file
- Profile last updated
- September 16, 2024
- Year of graduation
- 2006 — 20 yrs since
- Specialty taxonomy
- 207RI0200X — NUCC code
- State licenses (3)
- Illinois #036.171854 · New York #254085 · New Jersey #25MA09736100
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1871656215. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
62
Distinct HCPCS
2
Medicare allowed
$6,181
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 46 | 19 | $85 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 16 | 16 | $141 |
In context: peer comparison
Among 57 peers in this city , average services per provider: 229. This provider delivers 0.3× the peer median.Open Payments
Industry payments received
All-time total
$185
Transactions
8
Manufacturers
2
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ViiV Healthcare Company | 5 | $117.35 | |
| Merck Sharp & Dohme LLC | 3 | $67.82 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
941
Patients
83
Total drug cost
$1,230,674
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Biktarvy (Bictegrav/Emtricit/Tenofov Ala) | Brand | 192 | 34 | $824,514 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 131 | 20 | $3,579 |
| Atorvastatin Calcium | Generic | 103 | 18 | $793 |
| Fluticasone Propionate | Generic | 67 | 0 | $933 |
| Amlodipine Besylate | Generic | 48 | 11 | $316 |
| Ketoconazole | Generic | 48 | 0 | $630 |
| Gabapentin | Generic | 46 | 0 | $1,430 |
| Naloxone Hcl | Generic | 46 | 0 | $4,098 |
| Juluca (Dolutegravir/Rilpivirine) | Brand | 45 | 0 | $161,506 |
| Tivicay (Dolutegravir Sodium) | Brand | 42 | 0 | $98,896 |
Frequently asked questions
What is Dr. Michelle Dallapiazza's medical specialty?
Dr. Michelle Dallapiazza practices Infectious Disease Physician in Chicago, IL.
Where does Dr. Michelle Dallapiazza practice?
Dr. Michelle Dallapiazza practices at 4025 N Sheridan RD, Chicago, IL 606132010. Office phone: 7733881600.
What is Dr. Michelle Dallapiazza's NPI?
Dr. Michelle Dallapiazza's National Provider Identifier (NPI) is 1871656215, issued by NPPES.
Does Dr. Michelle Dallapiazza accept Medicare assignment?
Yes. Dr. Michelle Dallapiazza accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Michelle Dallapiazza commonly perform?
Top Medicare-reported procedures in 2023: Subsequent hospital care with moderate levelof medical decision making (HCPCS 99232); Initial hospital care with straightforward or low-level medical decision making (HCPCS 99222). Source: CMS Medicare Physician & Other Practitioners file.